25 XP   0   0   10

Anteo Diagnostics Ltd
Buy, Hold or Sell?

Let's analyse Anteo Diagnostics Ltd together

PenkeI guess you are interested in Anteo Diagnostics Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Anteo Diagnostics Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Anteo Diagnostics Ltd

I send you an email if I find something interesting about Anteo Diagnostics Ltd.

Quick analysis of Anteo Diagnostics Ltd (30 sec.)










What can you expect buying and holding a share of Anteo Diagnostics Ltd? (30 sec.)

How much money do you get?

How much money do you get?
A$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
A$0.00
Expected worth in 1 year
A$0.00
How sure are you?
28.2%

+ What do you gain per year?

Total Gains per Share
A$0.00
Return On Investment
-10.0%

For what price can you sell your share?

Current Price per Share
A$0.02
Expected price per share
A$0 - A$0.024
How sure are you?
50%

1. Valuation of Anteo Diagnostics Ltd (5 min.)




Live pricePrice per Share (EOD)

A$0.02

Intrinsic Value Per Share

A$-0.10 - A$-0.03

Total Value Per Share

A$-0.10 - A$-0.03

2. Growth of Anteo Diagnostics Ltd (5 min.)




Is Anteo Diagnostics Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$3m$7m-$4.7m-207.1%

How much money is Anteo Diagnostics Ltd making?

Current yearPrevious yearGrowGrow %
Making money-$3.4m-$2.5m-$914.6k-26.7%
Net Profit Margin-4,006.3%-772.5%--

How much money comes from the company's main activities?

3. Financial Health of Anteo Diagnostics Ltd (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#831 / 1016

Most Revenue
#598 / 1016

Most Profit
#514 / 1016

Most Efficient
#888 / 1016

What can you expect buying and holding a share of Anteo Diagnostics Ltd? (5 min.)

Welcome investor! Anteo Diagnostics Ltd's management wants to use your money to grow the business. In return you get a share of Anteo Diagnostics Ltd.

What can you expect buying and holding a share of Anteo Diagnostics Ltd?

First you should know what it really means to hold a share of Anteo Diagnostics Ltd. And how you can make/lose money.

Speculation

The Price per Share of Anteo Diagnostics Ltd is A$0.023. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Anteo Diagnostics Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Anteo Diagnostics Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is A$0.00. Based on the TTM, the Book Value Change Per Share is A$0.00 per quarter. Based on the YOY, the Book Value Change Per Share is A$0.00 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is A$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Anteo Diagnostics Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 A$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per Share
Usd Eps0.00-2.7%0.00-6.2%0.00-3.5%0.00-2.7%0.00-2.0%
Usd Book Value Change Per Share0.002.8%0.00-1.6%0.00-2.8%0.000.1%0.00-0.1%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.002.8%0.00-1.6%0.00-2.8%0.000.1%0.00-0.1%
Usd Price Per Share0.02-0.02-0.04-0.06-0.05-
Price to Earnings Ratio-9.21--5.67--14.05--32.11--40.95-
Price-to-Total Gains Ratio36.51--20.88--68.25--4,075,736.32--1,786,890.29-
Price to Book Ratio18.25-28.40-15.18-27.12-26.69-
Price-to-Total Gains Ratio36.51--20.88--68.25--4,075,736.32--1,786,890.29-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.0147729
Number of shares67691
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.00
Usd Total Gains Per Share0.000.00
Gains per Quarter (67691 shares)-24.932.11
Gains per Year (67691 shares)-99.748.42
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-100-11008-2
20-199-2100176
30-299-31002514
40-399-41003422
50-499-51004230
60-598-61005138
70-698-71005946
80-798-81006754
90-898-91007662
100-997-101008470

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.03.00.00.0%0.011.00.00.0%0.019.00.00.0%0.039.00.00.0%0.091.04.00.0%
Book Value Change Per Share1.02.00.033.3%2.06.03.018.2%5.08.06.026.3%11.018.010.028.2%34.036.025.035.8%
Dividend per Share0.00.03.00.0%0.00.011.00.0%0.00.019.00.0%0.00.039.00.0%20.00.075.021.1%
Total Gains per Share1.02.00.033.3%2.06.03.018.2%5.08.06.026.3%11.018.010.028.2%40.035.020.042.1%

Fundamentals of Anteo Diagnostics Ltd

About Anteo Diagnostics Ltd

AnteoTech Limited develops, commercializes, manufactures, and distributes products for clean energy technology and life science markets primarily in Australia, Asia, Europe, and North America. Its products include AnteoBind ready-to-use applications to streamline and enhance the conjugation process; and AnteoX, an additive that reinforces battery binders helping maximize performance of silicon containing anodes. The company was formerly known as Anteo Diagnostics Limited and changed its name to AnteoTech Limited in November 2019. AnteoTech Limited is headquartered in Eight Mile Plains, Australia.

Fundamental data was last updated by Penke on 2024-04-19 01:19:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Anteo Diagnostics Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Anteo Diagnostics Ltd earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Anteo Diagnostics Ltd to the Biotechnology industry mean.
  • A Net Profit Margin of -620.8% means that $-6.21 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Anteo Diagnostics Ltd:

  • The MRQ is -620.8%. The company is making a huge loss. -2
  • The TTM is -4,006.3%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-620.8%TTM-4,006.3%+3,385.5%
TTM-4,006.3%YOY-772.5%-3,233.8%
TTM-4,006.3%5Y-1,391.2%-2,615.1%
5Y-1,391.2%10Y-1,275.5%-115.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-620.8%-197.2%-423.6%
TTM-4,006.3%-210.4%-3,795.9%
YOY-772.5%-279.3%-493.2%
5Y-1,391.2%-436.8%-954.4%
10Y-1,275.5%-599.3%-676.2%
1.1.2. Return on Assets

Shows how efficient Anteo Diagnostics Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Anteo Diagnostics Ltd to the Biotechnology industry mean.
  • -31.8% Return on Assets means that Anteo Diagnostics Ltd generated $-0.32 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Anteo Diagnostics Ltd:

  • The MRQ is -31.8%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -95.5%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-31.8%TTM-95.5%+63.7%
TTM-95.5%YOY-28.3%-67.2%
TTM-95.5%5Y-33.1%-62.4%
5Y-33.1%10Y-23.4%-9.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-31.8%-13.6%-18.2%
TTM-95.5%-12.9%-82.6%
YOY-28.3%-11.9%-16.4%
5Y-33.1%-14.2%-18.9%
10Y-23.4%-16.2%-7.2%
1.1.3. Return on Equity

Shows how efficient Anteo Diagnostics Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Anteo Diagnostics Ltd to the Biotechnology industry mean.
  • -49.5% Return on Equity means Anteo Diagnostics Ltd generated $-0.50 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Anteo Diagnostics Ltd:

  • The MRQ is -49.5%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -144.3%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-49.5%TTM-144.3%+94.7%
TTM-144.3%YOY-38.9%-105.4%
TTM-144.3%5Y-45.1%-99.2%
5Y-45.1%10Y-33.6%-11.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-49.5%-17.0%-32.5%
TTM-144.3%-16.1%-128.2%
YOY-38.9%-15.4%-23.5%
5Y-45.1%-20.0%-25.1%
10Y-33.6%-21.1%-12.5%

1.2. Operating Efficiency of Anteo Diagnostics Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Anteo Diagnostics Ltd is operating .

  • Measures how much profit Anteo Diagnostics Ltd makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Anteo Diagnostics Ltd to the Biotechnology industry mean.
  • An Operating Margin of -1,625.7% means the company generated $-16.26  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Anteo Diagnostics Ltd:

  • The MRQ is -1,625.7%. The company is operating very inefficient. -2
  • The TTM is -3,275.1%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-1,625.7%TTM-3,275.1%+1,649.3%
TTM-3,275.1%YOY-1,058.2%-2,216.9%
TTM-3,275.1%5Y-1,341.3%-1,933.8%
5Y-1,341.3%10Y-841.7%-499.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-1,625.7%-286.1%-1,339.6%
TTM-3,275.1%-224.4%-3,050.7%
YOY-1,058.2%-288.4%-769.8%
5Y-1,341.3%-475.2%-866.1%
10Y-841.7%-624.7%-217.0%
1.2.2. Operating Ratio

Measures how efficient Anteo Diagnostics Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 15.98 means that the operating costs are $15.98 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Anteo Diagnostics Ltd:

  • The MRQ is 15.975. The company is inefficient in keeping operating costs low. -1
  • The TTM is 30.605. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ15.975TTM30.605-14.629
TTM30.605YOY7.945+22.659
TTM30.6055Y9.471+21.134
5Y9.47110Y10.084-0.613
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ15.9752.997+12.978
TTM30.6053.247+27.358
YOY7.9453.766+4.179
5Y9.4715.675+3.796
10Y10.0847.857+2.227

1.3. Liquidity of Anteo Diagnostics Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Anteo Diagnostics Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 2.90 means the company has $2.90 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Anteo Diagnostics Ltd:

  • The MRQ is 2.905. The company is able to pay all its short-term debts. +1
  • The TTM is 2.129. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.905TTM2.129+0.776
TTM2.129YOY5.534-3.405
TTM2.1295Y9.099-6.970
5Y9.09910Y6.614+2.485
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.9053.930-1.025
TTM2.1294.251-2.122
YOY5.5345.436+0.098
5Y9.0996.045+3.054
10Y6.6146.363+0.251
1.3.2. Quick Ratio

Measures if Anteo Diagnostics Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Anteo Diagnostics Ltd to the Biotechnology industry mean.
  • A Quick Ratio of 2.79 means the company can pay off $2.79 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Anteo Diagnostics Ltd:

  • The MRQ is 2.791. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 2.008. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ2.791TTM2.008+0.783
TTM2.008YOY5.398-3.390
TTM2.0085Y5.186-3.178
5Y5.18610Y4.035+1.152
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.7913.629-0.838
TTM2.0084.065-2.057
YOY5.3985.397+0.001
5Y5.1865.993-0.807
10Y4.0356.277-2.242

1.4. Solvency of Anteo Diagnostics Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Anteo Diagnostics Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Anteo Diagnostics Ltd to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.36 means that Anteo Diagnostics Ltd assets are financed with 35.8% credit (debt) and the remaining percentage (100% - 35.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Anteo Diagnostics Ltd:

  • The MRQ is 0.358. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.417. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.358TTM0.417-0.059
TTM0.417YOY0.188+0.229
TTM0.4175Y0.197+0.220
5Y0.19710Y0.256-0.059
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3580.332+0.026
TTM0.4170.334+0.083
YOY0.1880.268-0.080
5Y0.1970.366-0.169
10Y0.2560.390-0.134
1.4.2. Debt to Equity Ratio

Measures if Anteo Diagnostics Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Anteo Diagnostics Ltd to the Biotechnology industry mean.
  • A Debt to Equity ratio of 55.8% means that company has $0.56 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Anteo Diagnostics Ltd:

  • The MRQ is 0.558. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.605. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.558TTM0.605-0.047
TTM0.605YOY0.266+0.339
TTM0.6055Y0.260+0.344
5Y0.26010Y0.772-0.511
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5580.381+0.177
TTM0.6050.390+0.215
YOY0.2660.334-0.068
5Y0.2600.434-0.174
10Y0.7720.466+0.306

2. Market Valuation of Anteo Diagnostics Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Anteo Diagnostics Ltd generates.

  • Above 15 is considered overpriced but always compare Anteo Diagnostics Ltd to the Biotechnology industry mean.
  • A PE ratio of -9.21 means the investor is paying $-9.21 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Anteo Diagnostics Ltd:

  • The EOD is -5.884. Based on the earnings, the company is expensive. -2
  • The MRQ is -9.209. Based on the earnings, the company is expensive. -2
  • The TTM is -5.670. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-5.884MRQ-9.209+3.326
MRQ-9.209TTM-5.670-3.540
TTM-5.670YOY-14.052+8.383
TTM-5.6705Y-32.112+26.442
5Y-32.11210Y-40.953+8.841
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-5.884-2.315-3.569
MRQ-9.209-2.560-6.649
TTM-5.670-2.664-3.006
YOY-14.052-4.122-9.930
5Y-32.112-6.258-25.854
10Y-40.953-6.108-34.845
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Anteo Diagnostics Ltd:

  • The EOD is -6.803. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -10.649. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -8.033. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-6.803MRQ-10.649+3.845
MRQ-10.649TTM-8.033-2.615
TTM-8.033YOY-7.951-0.083
TTM-8.0335Y-69.192+61.159
5Y-69.19210Y-63.184-6.009
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-6.803-3.067-3.736
MRQ-10.649-3.251-7.398
TTM-8.033-3.545-4.488
YOY-7.951-5.595-2.356
5Y-69.192-8.315-60.877
10Y-63.184-8.708-54.476
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Anteo Diagnostics Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 18.25 means the investor is paying $18.25 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Anteo Diagnostics Ltd:

  • The EOD is 11.659. Based on the equity, the company is expensive. -2
  • The MRQ is 18.249. Based on the equity, the company is expensive. -2
  • The TTM is 28.395. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD11.659MRQ18.249-6.590
MRQ18.249TTM28.395-10.146
TTM28.395YOY15.176+13.219
TTM28.3955Y27.118+1.277
5Y27.11810Y26.693+0.425
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD11.6591.905+9.754
MRQ18.2492.111+16.138
TTM28.3952.095+26.300
YOY15.1762.836+12.340
5Y27.1183.443+23.675
10Y26.6933.794+22.899
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Anteo Diagnostics Ltd.

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Anteo Diagnostics Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.001-0.001+158%-0.001+200%0.000+1936%0.000+103%
Book Value Per Share--0.0020.001+33%0.005-57%0.003-41%0.003-33%
Current Ratio--2.9052.129+36%5.534-48%9.099-68%6.614-56%
Debt To Asset Ratio--0.3580.417-14%0.188+90%0.197+82%0.256+40%
Debt To Equity Ratio--0.5580.605-8%0.266+110%0.260+114%0.772-28%
Dividend Per Share----0%-0%-0%-0%
Eps---0.001-0.002+127%-0.001+30%-0.001-2%-0.001-27%
Free Cash Flow Per Share---0.001-0.001+63%-0.002+97%-0.001-4%-0.001-32%
Free Cash Flow To Equity Per Share--0.001-0.001+163%-0.002+309%-0.001+190%-0.001+193%
Gross Profit Margin--1.0001.064-6%1.163-14%1.070-6%1.168-14%
Intrinsic Value_10Y_max---0.032--------
Intrinsic Value_10Y_min---0.098--------
Intrinsic Value_1Y_max---0.002--------
Intrinsic Value_1Y_min---0.007--------
Intrinsic Value_3Y_max---0.008--------
Intrinsic Value_3Y_min---0.023--------
Intrinsic Value_5Y_max---0.014--------
Intrinsic Value_5Y_min---0.042--------
Market Cap55394121.472-57%86703842.30492323535.787-6%167988694.464-48%222590565.915-61%193070436.310-55%
Net Profit Margin---6.208-40.063+545%-7.725+24%-13.912+124%-12.755+105%
Operating Margin---16.257-32.751+101%-10.582-35%-13.413-17%-8.417-48%
Operating Ratio--15.97530.605-48%7.945+101%9.471+69%10.084+58%
Pb Ratio11.659-57%18.24928.395-36%15.176+20%27.118-33%26.693-32%
Pe Ratio-5.884+36%-9.209-5.670-38%-14.052+53%-32.112+249%-40.953+345%
Price Per Share0.023-57%0.0360.038-6%0.070-48%0.092-61%0.080-55%
Price To Free Cash Flow Ratio-6.803+36%-10.649-8.033-25%-7.951-25%-69.192+550%-63.184+493%
Price To Total Gains Ratio23.328-57%36.514-20.879+157%-68.246+287%-4075736.324+11162201%-1786890.291+4893805%
Quick Ratio--2.7912.008+39%5.398-48%5.186-46%4.035-31%
Return On Assets---0.318-0.955+200%-0.283-11%-0.331+4%-0.234-26%
Return On Equity---0.495-1.443+191%-0.389-22%-0.451-9%-0.336-32%
Total Gains Per Share--0.001-0.001+158%-0.001+200%0.000+1936%0.000+103%
Usd Book Value--3051646.3032287785.890+33%7025151.433-57%5132954.175-41%4533478.650-33%
Usd Book Value Change Per Share--0.0010.000+158%-0.001+200%0.000+1936%0.000+103%
Usd Book Value Per Share--0.0010.001+33%0.003-57%0.002-41%0.002-33%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.001-0.001+127%-0.001+30%-0.001-2%0.000-27%
Usd Free Cash Flow---1307429.269-2132070.960+63%-1930732.444+48%-793189.691-39%-658328.786-50%
Usd Free Cash Flow Per Share---0.001-0.001+63%-0.001+97%-0.001-4%0.000-32%
Usd Free Cash Flow To Equity Per Share--0.0010.000+163%-0.001+309%0.000+190%0.000+193%
Usd Market Cap35579644.221-57%55689877.91259299407.036-6%107899138.454-48%142969920.487-61%124009141.242-55%
Usd Price Per Share0.015-57%0.0230.025-6%0.045-48%0.059-61%0.051-55%
Usd Profit---1511768.022-3429337.330+127%-2514670.978+66%-1735181.259+15%-1264743.140-16%
Usd Revenue--243520.980-239267.669+198%391431.269-38%117969.365+106%305066.424-20%
Usd Total Gains Per Share--0.0010.000+158%-0.001+200%0.000+1936%0.000+103%
 EOD+2 -6MRQTTM+30 -4YOY+16 -185Y+13 -2110Y+11 -23

4.2. Fundamental Score

Let's check the fundamental score of Anteo Diagnostics Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-5.884
Price to Book Ratio (EOD)Between0-111.659
Net Profit Margin (MRQ)Greater than0-6.208
Operating Margin (MRQ)Greater than0-16.257
Quick Ratio (MRQ)Greater than12.791
Current Ratio (MRQ)Greater than12.905
Debt to Asset Ratio (MRQ)Less than10.358
Debt to Equity Ratio (MRQ)Less than10.558
Return on Equity (MRQ)Greater than0.15-0.495
Return on Assets (MRQ)Greater than0.05-0.318
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Anteo Diagnostics Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5028.195
Ma 20Greater thanMa 500.030
Ma 50Greater thanMa 1000.033
Ma 100Greater thanMa 2000.034
OpenGreater thanClose0.022
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in AUD. All numbers in thousands.

Summary
Total Assets7,400
Total Liabilities2,649
Total Stockholder Equity4,751
 As reported
Total Liabilities 2,649
Total Stockholder Equity+ 4,751
Total Assets = 7,400

Assets

Total Assets7,400
Total Current Assets5,105
Long-term Assets2,295
Total Current Assets
Cash And Cash Equivalents 4,640
Net Receivables 266
Other Current Assets 199
Total Current Assets  (as reported)5,105
Total Current Assets  (calculated)5,105
+/-0
Long-term Assets
Property Plant Equipment 2,295
Long-term Assets Other 0
Long-term Assets  (as reported)2,295
Long-term Assets  (calculated)2,295
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities1,758
Long-term Liabilities892
Total Stockholder Equity4,751
Total Current Liabilities
Short-term Debt 643
Accounts payable 629
Other Current Liabilities 486
Total Current Liabilities  (as reported)1,758
Total Current Liabilities  (calculated)1,758
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)892
Long-term Liabilities  (calculated)0
+/- 892
Total Stockholder Equity
Common Stock93,579
Retained Earnings -93,370
Accumulated Other Comprehensive Income 4,541
Total Stockholder Equity (as reported)4,751
Total Stockholder Equity (calculated)4,751
+/-0
Other
Cash and Short Term Investments 4,640
Common Stock Shares Outstanding 2,139,708
Liabilities and Stockholders Equity 7,400
Net Debt -3,647
Short Long Term Debt Total 993



Balance Sheet

Currency in AUD. All numbers in thousands.

 Trend2023-12-312023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-09-302001-06-302001-03-312000-12-312000-09-302000-06-302000-03-311999-12-311999-09-301999-06-301999-03-311998-12-31
> Total Assets 
0
0
0
0
0
7,933
7,933
7,494
7,494
11,528
11,527
15,450
15,450
7,971
7,971
8,079
8,079
5,037
5,037
5,285
5,285
3,435
3,435
1,723
1,723
732
732
0
4,446
1,909
1,909
1,452
1,452
1,959
1,959
1,310
1,310
3,472
3,472
2,113
2,113
1,332
1,332
1,426
1,426
1,723
1,723
2,522
2,522
7,285
7,285
5,872
5,872
5,211
5,211
4,555
4,555
3,275
3,275
7,955
7,955
7,667
7,667
7,662
7,662
6,043
6,043
6,009
6,397
35,236
52,599
35,682
35,682
30,833
45,814
5,350
5,350
4,470
4,470
2,983
2,983
4,768
4,768
3,976
3,976
0
3,909
0
6,990
0
23,675
0
20,661
15,264
15,264
11,687
11,687
5,362
5,362
7,400
7,4005,3625,36211,68711,68715,26415,26420,661023,67506,99003,90903,9763,9764,7684,7682,9832,9834,4704,4705,3505,35045,81430,83335,68235,68252,59935,2366,3976,0096,0436,0437,6627,6627,6677,6677,9557,9553,2753,2754,5554,5555,2115,2115,8725,8727,2857,2852,5222,5221,7231,7231,4261,4261,3321,3322,1132,1133,4723,4721,3101,3101,9591,9591,4521,4521,9091,9094,44607327321,7231,7233,4353,4355,2855,2855,0375,0378,0798,0797,9717,97115,45015,45011,52711,5287,4947,4947,9337,93300000
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
6,470
0
0
0
5,172
0
0
0
3,317
0
0
0
2,567
0
0
0
542
0
0
0
1,428
0
0
0
1,483
0
0
0
3,260
0
0
0
1,031
0
0
0
1,481
0
0
0
7,003
0
0
0
4,929
0
0
0
3,024
0
0
0
7,314
0
0
0
5,503
0
0
0
16,365
11,735
11,735
30,577
45,433
5,037
5,037
4,191
4,191
2,594
2,594
4,456
4,456
3,241
3,241
3,378
3,378
6,518
6,518
21,789
21,789
17,030
17,030
10,826
10,826
6,739
6,739
3,142
3,142
5,105
5,1053,1423,1426,7396,73910,82610,82617,03017,03021,78921,7896,5186,5183,3783,3783,2413,2414,4564,4562,5942,5944,1914,1915,0375,03745,43330,57711,73511,73516,3650005,5030007,3140003,0240004,9290007,0030001,4810001,0310003,2600001,4830001,4280005420002,5670003,3170005,1720006,4700000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
5,568
0
0
0
3,764
0
0
0
1,247
0
0
0
422
0
0
0
297
0
0
0
1,294
0
0
0
1,281
0
0
0
3,121
0
0
0
953
0
0
0
1,426
0
0
0
6,864
0
0
0
4,883
0
0
0
2,621
0
0
0
7,071
0
0
0
5,207
0
0
0
3,765
2,331
2,331
642
1,062
4,919
4,919
3,329
3,329
2,301
2,301
4,276
4,276
2,112
2,112
0
3,215
0
6,434
0
21,392
0
16,614
10,103
10,103
6,425
6,425
2,720
2,720
4,640
4,6402,7202,7206,4256,42510,10310,10316,614021,39206,43403,21502,1122,1124,2764,2762,3012,3013,3293,3294,9194,9191,0626422,3312,3313,7650005,2070007,0710002,6210004,8830006,8640001,4260009530003,1210001,2810001,2940002970004220001,2470003,7640005,5680000000000
       Net Receivables 
0
0
0
0
0
0
0
144
144
69
92
129
129
509
514
2,153
2,153
864
870
911
911
624
624
173
173
1
1
0
155
128
128
27
27
173
173
165
165
138
138
41
41
76
76
67
67
53
53
637
637
137
137
31
31
43
43
43
43
402
402
128
128
234
234
142
142
243
243
1,212
1,290
4,968
7,416
5,887
5,887
91
28
55
55
49
794
66
192
75
75
82
82
73
73
84
84
242
242
305
305
469
469
136
136
198
198
266
26619819813613646946930530524224284847373828275751926679449555528915,8875,8877,4164,9681,2901,212243243142142234234128128402402434343433131137137637637535367677676414113813816516517317327271281281550111731736246249119118708642,1532,15351450912912992691441440000000
       Other Current Assets 
0
0
0
0
0
44
44
50
50
153
153
54
54
117
117
369
369
157
157
151
151
78
78
61
61
9
9
0
17
6
6
53
53
28
28
73
73
1
1
16
16
2
2
18
18
2
2
21
21
2
2
23
23
2
3
21
21
2
2
30
30
10
10
74
74
54
54
45
48
72
108
53
53
29,843
44,343
63
63
745
69
126
101
105
105
967
967
0
91
0
0
155
155
0
111
254
254
0
177
0
225
199
1992250177025425411101551550091096796710510510112669745636344,34329,843535310872484554547474101030302221213223232221212218182216161173732828535366170996161787815115115715736936911711754541531535050444400000
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
5,058
0
0
0
2,799
0
0
0
1,720
0
0
0
868
0
0
0
190
0
0
0
481
0
0
0
476
0
0
0
212
0
0
0
302
0
0
0
242
0
0
0
282
0
0
0
283
0
0
0
251
0
0
0
353
0
0
0
540
0
0
0
36,234
0
0
0
381
0
0
0
279
0
0
0
312
0
0
0
531
0
0
0
1,886
0
0
4,438
4,438
4,457
4,949
2,220
2,220
2,295
2,2952,2202,2204,9494,4574,4384,438001,88600053100031200027900038100036,2340005400003530002510002830002820002420003020002120004760004810001900008680001,7200002,7990005,0580000000000
       Property Plant Equipment 
0
0
0
0
0
292
292
564
564
965
4,438
1,604
1,604
1,074
2,277
1,277
1,277
1,273
1,273
944
944
737
737
222
222
123
123
0
589
481
481
360
360
476
476
395
395
212
212
340
340
302
302
276
276
242
242
269
269
282
282
290
290
283
283
294
294
251
251
321
321
353
353
594
594
540
540
382
406
15,374
22,950
14,917
14,917
256
381
313
313
279
279
389
389
312
312
735
735
531
531
472
472
1,886
1,886
2,975
2,975
4,015
4,015
4,457
4,457
2,220
2,220
2,295
2,2952,2202,2204,4574,4574,0154,0152,9752,9751,8861,88647247253153173573531231238938927927931331338125614,91714,91722,95015,37440638254054059459435335332132125125129429428328329029028228226926924224227627630230234034021221239539547647636036048148158901231232222227377379449441,2731,2731,2771,2772,2771,0741,6041,6044,43896556456429229200000
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6,649
9,925
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000009,9256,649000000000000000000000000000000000000000000000000000000000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5
5
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000005500000000000000000000000000000000000000000000000000000000000000000000000
       Intangible Assets 
0
0
0
0
0
216
216
1,035
1,035
383
619
438
438
456
522
516
516
447
447
449
449
131
131
129
129
67
67
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
8,894
3,351
8,894
8,894
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000008,8948,8943,3518,89400000000000000000000000000000000000000000067671291291311314494494474475165165224564384386193831,0351,03521621600000
       Other Assets 
0
0
0
0
0
1,773
1,773
2,655
2,655
4,093
4,093
6,031
6,031
1,725
1,725
1,996
1,996
447
447
449
449
131
131
129
129
67
67
0
1,071
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
8,899
8,899
9,030
9,030
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
656
656
423
0
491
491
0
0
0
00049149104236566560000000000000000009,0309,0308,8998,89900000000000000000000000000000000000000001,071067671291291311314494494474471,9961,9961,7251,7256,0316,0314,0934,0932,6552,6551,7731,77300000
> Total Liabilities 
0
0
0
0
0
618
618
808
808
1,328
1,328
2,140
2,140
1,598
1,598
1,317
1,317
1,582
1,582
1,444
1,444
1,327
1,327
309
309
205
205
0
277
317
317
381
381
409
409
405
405
462
462
273
273
300
300
259
259
329
329
348
348
394
394
486
486
439
439
382
382
500
500
574
574
566
566
658
658
696
696
736
783
25,921
38,693
27,734
27,734
26,052
38,711
568
568
468
468
448
448
533
533
798
798
0
700
0
823
0
2,561
0
2,241
2,909
2,909
1,543
2,792
1,804
2,986
2,649
2,6492,9861,8042,7921,5432,9092,9092,24102,56108230700079879853353344844846846856856838,71126,05227,73427,73438,69325,92178373669669665865856656657457450050038238243943948648639439434834832932925925930030027327346246240540540940938138131731727702052053093091,3271,3271,4441,4441,5821,5821,3171,3171,5981,5982,1402,1401,3281,32880880861861800000
   > Total Current Liabilities 
0
0
0
0
0
593
593
725
725
1,156
1,156
1,961
1,961
1,435
1,435
1,121
1,121
1,443
1,443
1,353
1,353
1,272
1,272
309
309
205
205
0
277
317
317
381
381
409
409
405
405
462
462
273
273
300
300
259
259
329
329
348
348
394
394
486
486
439
439
382
382
439
500
574
574
483
483
582
582
602
602
676
719
11,510
17,182
13,229
13,229
26,028
38,675
553
553
450
450
275
275
347
347
619
619
623
623
794
794
1,084
1,084
835
835
1,616
1,616
1,543
1,543
1,804
1,804
1,758
1,7581,8041,8041,5431,5431,6161,6168358351,0841,08479479462362361961934734727527545045055355338,67526,02813,22913,22917,18211,51071967660260258258248348357457450043938238243943948648639439434834832932925925930030027327346246240540540940938138131731727702052053093091,2721,2721,3531,3531,4431,4431,1211,1211,4351,4351,9611,9611,1561,15672572559359300000
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
91
0
0
0
115
0
0
0
37
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
11,242
0
0
561
561
0
0
0
0
0
0
0
0
0
0
0
135
0
0
0
277
0
0
258
258
0
578
0
648
643
6436480578025825800277000135000000000005615610011,24200000000000000000000000000000000000000000003700011500091000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
561
561
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000005615610000000000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
0
0
0
0
0
234
234
641
641
723
723
0
0
351
351
0
0
699
699
0
0
629
629
0
0
58
58
0
245
71
71
300
300
35
35
0
0
102
102
0
0
33
33
0
0
72
72
0
0
48
48
0
0
90
90
0
0
144
144
0
0
165
165
0
0
227
227
0
0
2,092
2,092
2,698
2,698
247
247
368
368
153
153
184
184
130
130
205
205
61
61
398
398
390
390
249
249
704
903
564
564
533
746
629
62974653356456490370424924939039039839861612052051301301841841531533683682472472,6982,6982,0922,092002272270016516500144144009090004848007272003333001021020035353003007171245058580062962900699699003513510072372364164123423400000
       Other Current Liabilities 
0
0
0
0
0
348
348
45
45
385
433
1,738
1,738
894
1,084
1,022
1,022
654
653
1,260
1,260
528
528
250
250
110
110
0
33
246
246
81
81
374
374
405
405
360
360
274
274
267
267
259
259
256
257
347
347
346
346
485
485
348
349
382
382
294
355
574
574
319
318
582
582
375
374
675
719
7,241
2,817
10,531
10,531
25,219
38,308
184
184
128
297
91
91
105
218
165
165
273
427
388
388
174
417
336
336
655
456
978
401
1,272
410
486
4864101,272401978456655336336417174388388427273165165218105919129712818418438,30825,21910,53110,5312,8177,24171967537437558258231831957457435529438238234934848548534634634734725725625925926726727427436036040540537437481812462463301101102502505285281,2601,2606536541,0221,0221,0848941,7381,738433385454534834800000
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
172
0
0
0
164
0
0
0
138
0
0
0
55
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
83
0
0
0
95
0
0
0
21,511
0
0
0
36
0
0
0
18
0
0
0
185
0
0
0
77
0
0
0
1,477
0
0
1,293
1,293
0
1,250
0
1,181
892
8921,18101,25001,2931,293001,47700077000185000180003600021,5110009500083000000000000000000000000000000000000000550001380001640001720000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
8
0
0
0
0
0
1,005
0
913
0
776
0
629
0
659
0
065906290776091301,005000008000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
7
7
7
7
0
0
0
0
32
32
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
60
60
0
0
83
83
77
77
95
95
60
64
6,704
6,704
10,238
10,238
24
24
15
15
18
18
172
172
185
185
171
171
77
77
29
29
472
472
493
493
517
517
620
620
523
523
0
05235236206205175174934934724722929777717117118518517217218181515242410,23810,2386,7046,704646095957777838300606000000000000000000000000000000000003232000077770000000000000
> Total Stockholder Equity
0
0
0
0
0
7,315
7,315
6,686
6,686
10,199
10,199
13,310
13,310
6,373
6,373
6,762
6,762
3,456
3,456
3,841
3,841
2,108
2,108
1,414
1,414
527
527
0
4,168
1,592
1,592
1,071
1,071
1,550
1,550
905
905
3,010
3,010
1,840
1,840
1,033
1,033
1,167
1,167
1,394
1,394
2,174
2,174
6,891
6,891
5,386
5,386
4,773
4,773
4,173
4,173
2,776
2,776
7,381
7,381
7,101
7,101
7,003
7,003
5,347
5,347
5,274
5,614
9,315
13,906
7,948
7,948
4,781
7,103
4,782
4,782
4,002
4,002
2,535
2,535
4,235
4,235
3,178
3,178
0
3,209
0
6,167
0
21,114
0
18,420
12,355
12,355
5,565
8,895
-1,714
2,377
4,751
4,7512,377-1,7148,8955,56512,35512,35518,420021,11406,16703,20903,1783,1784,2354,2352,5352,5354,0024,0024,7824,7827,1034,7817,9487,94813,9069,3155,6145,2745,3475,3477,0037,0037,1017,1017,3817,3812,7762,7764,1734,1734,7734,7735,3865,3866,8916,8912,1742,1741,3941,3941,1671,1671,0331,0331,8401,8403,0103,0109059051,5501,5501,0711,0711,5921,5924,16805275271,4141,4142,1082,1083,8413,8413,4563,4566,7626,7626,3736,37313,31013,31010,19910,1996,6866,6867,3157,31500000
   Common Stock
0
0
0
0
0
7,883
7,883
7,882
7,882
12,169
12,169
17,503
17,503
17,506
17,506
17,506
17,506
17,535
17,535
19,068
19,068
19,063
19,063
19,063
19,063
19,126
19,126
0
16,593
16,559
16,746
16,559
16,559
16,859
16,859
16,859
16,859
21,467
21,536
21,467
21,467
21,467
21,467
22,669
22,669
24,082
24,153
25,811
25,811
31,750
31,859
31,750
31,750
31,808
32,121
31,913
31,913
31,969
31,969
37,122
37,122
38,658
38,658
39,610
39,610
40,610
40,610
29,407
31,302
36,961
55,175
38,790
38,790
40,444
60,095
59,062
59,062
59,062
59,062
59,181
59,181
62,421
62,421
62,458
62,458
64,292
64,292
68,137
68,137
86,209
86,209
87,041
87,041
87,454
87,454
87,472
87,472
89,302
89,302
93,579
93,57989,30289,30287,47287,47287,45487,45487,04187,04186,20986,20968,13768,13764,29264,29262,45862,45862,42162,42159,18159,18159,06259,06259,06259,06260,09540,44438,79038,79055,17536,96131,30229,40740,61040,61039,61039,61038,65838,65837,12237,12231,96931,96931,91331,91332,12131,80831,75031,75031,85931,75025,81125,81124,15324,08222,66922,66921,46721,46721,46721,46721,53621,46716,85916,85916,85916,85916,55916,55916,74616,55916,593019,12619,12619,06319,06319,06319,06319,06819,06817,53517,53517,50617,50617,50617,50617,50317,50312,16912,1697,8827,8827,8837,88300000
   Retained Earnings Total Equity0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
0
0
0
0
0
-188
0
0
0
-358
0
0
0
-708
0
0
0
-1,022
0
0
0
-747
0
0
0
-1,129
0
0
0
212
0
0
0
-1,322
0
0
0
70
0
0
0
-1,413
0
0
0
-1,404
0
0
0
-1,512
0
0
0
329
0
0
0
456
0
0
0
968
0
0
0
508
0
0
0
1,313
0
0
0
788
0
0
0
170
0
0
0
347
0
0
0
2,550
0
0
3,263
3,263
0
3,330
0
4,091
4,541
4,5414,09103,33003,2633,263002,5500003470001700007880001,313000508000968000456000329000-1,512000-1,404000-1,41300070000-1,322000212000-1,129000-747000-1,022000-708000-358000-1880000000000
   Capital Surplus 0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
188
0
0
0
358
0
0
0
708
0
0
0
1,022
0
0
0
747
0
0
0
1,129
0
0
0
2,720
0
0
0
1,322
0
0
0
1,476
0
0
0
1,413
0
0
0
1,404
0
0
0
1,512
0
0
0
1,808
0
0
0
2,039
0
0
0
2,713
0
0
0
4,891
444
444
882
3,195
869
869
788
2,795
19
19
170
2,331
130
130
347
2,363
926
926
2,550
2,550
2,845
2,845
3,263
3,263
-5,565
-5,565
1,714
0
0
001,714-5,565-5,5653,2633,2632,8452,8452,5502,5509269262,3633471301302,33117019192,7957888698693,1958824444444,8910002,7130002,0390001,8080001,5120001,4040001,4130001,4760001,3220002,7200001,1290007470001,0220007080003580001880000000000



Balance Sheet

Currency in AUD. All numbers in thousands.




Cash Flow

Currency in AUD. All numbers in thousands.




Income Statement

Currency in AUD. All numbers in thousands.


Latest Income Statement (annual, 2023-06-30)

Gross Profit (+$)
totalRevenue366
Cost of Revenue--
Gross Profit366366
 
Operating Income (+$)
Gross Profit366
Operating Expense-12,719
Operating Income-13,352-12,353
 
Operating Expense (+$)
Research Development5,842
Selling General Administrative5,009
Selling And Marketing Expenses1,740
Operating Expense12,71912,591
 
Net Interest Income (+$)
Interest Income40
Interest Expense--
Other Finance Cost-31
Net Interest Income9
 
Pretax Income (+$)
Operating Income-13,352
Net Interest Income9
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-15,854-10,849
EBIT - interestExpense = -13,352
-15,854
-12,654
Interest Expense-
Earnings Before Interest and Taxes (EBIT)-13,352-15,854
Earnings Before Interest and Taxes (EBITDA)-12,353
 
After tax Income (+$)
Income Before Tax-15,854
Tax Provision-0
Net Income From Continuing Ops-12,654-15,854
Net Income-12,654
Net Income Applicable To Common Shares-12,654
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items0
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses13,717
Total Other Income/Expenses Net-2,503-9
 

Technical Analysis of Anteo Diagnostics Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Anteo Diagnostics Ltd. The general trend of Anteo Diagnostics Ltd is BEARISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Anteo Diagnostics Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-71.4%) Bearish trend (71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Anteo Diagnostics Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 0.024 < 0.024 < 0.024.

The bearish price targets are: .

Tweet this
Anteo Diagnostics Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Anteo Diagnostics Ltd. The current mas is .

The long score for the Moving Averages is 2/14.
The longshort score for the Moving Averages is -10/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Anteo Diagnostics Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Anteo Diagnostics Ltd. The current macd is -0.00374325.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Anteo Diagnostics Ltd price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Anteo Diagnostics Ltd. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Anteo Diagnostics Ltd price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Anteo Diagnostics Ltd Daily Moving Average Convergence/Divergence (MACD) ChartAnteo Diagnostics Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Anteo Diagnostics Ltd. The current adx is 43.65.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Anteo Diagnostics Ltd shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
Anteo Diagnostics Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Anteo Diagnostics Ltd. The current sar is 0.03036468.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Anteo Diagnostics Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Anteo Diagnostics Ltd. The current rsi is 28.20. The current phase is Oversold in bear market.

The long score for the Relative Strength Index (RSI) is 2/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Oversold in bear market: Short-term excessive selling, potential for relief rally. Be cautious, consider taking short-term long positions. +1
  • Trending up: The RSI is trending up. +1
Anteo Diagnostics Ltd Daily Relative Strength Index (RSI) ChartAnteo Diagnostics Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Anteo Diagnostics Ltd. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Anteo Diagnostics Ltd price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Anteo Diagnostics Ltd Daily Stochastic Oscillator ChartAnteo Diagnostics Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Anteo Diagnostics Ltd. The current cci is -77.60942761.

Anteo Diagnostics Ltd Daily Commodity Channel Index (CCI) ChartAnteo Diagnostics Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Anteo Diagnostics Ltd. The current cmo is -49.28803963.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Anteo Diagnostics Ltd Daily Chande Momentum Oscillator (CMO) ChartAnteo Diagnostics Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Anteo Diagnostics Ltd. The current willr is -87.5.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Anteo Diagnostics Ltd Daily Williams %R ChartAnteo Diagnostics Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Anteo Diagnostics Ltd.

Anteo Diagnostics Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Anteo Diagnostics Ltd. The current atr is 0.00199758.

Anteo Diagnostics Ltd Daily Average True Range (ATR) ChartAnteo Diagnostics Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Anteo Diagnostics Ltd. The current obv is -156,603,775.

Anteo Diagnostics Ltd Daily On-Balance Volume (OBV) ChartAnteo Diagnostics Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Anteo Diagnostics Ltd. The current mfi is 7.31714279.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
Anteo Diagnostics Ltd Daily Money Flow Index (MFI) ChartAnteo Diagnostics Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Anteo Diagnostics Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-27RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2023-11-28ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-11-29STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-11-30STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-04STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-05STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-07STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-12STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-13SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-19CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-22CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-28STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-29CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-04STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-09ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-16MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-17STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-18SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-29BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-30STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-12STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-14MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-15DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-20DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-02-21STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-22STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-27CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-05CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-06DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-03-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-11STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-19CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-20MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-21STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-22CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-25STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-28SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-03CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-08BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-18STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Anteo Diagnostics Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Anteo Diagnostics Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5028.195
Ma 20Greater thanMa 500.030
Ma 50Greater thanMa 1000.033
Ma 100Greater thanMa 2000.034
OpenGreater thanClose0.022
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Anteo Diagnostics Ltd with someone you think should read this too:
  • Are you bullish or bearish on Anteo Diagnostics Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Anteo Diagnostics Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Anteo Diagnostics Ltd

I send you an email if I find something interesting about Anteo Diagnostics Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Anteo Diagnostics Ltd.

Receive notifications about Anteo Diagnostics Ltd in your mailbox!